Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Orthovita reports positive data from Cortoss clinical studies

Orthovita reports positive data from Cortoss clinical studies

22nd September 2010

Orthovita has published new data from clinical pilot studies which support the safety and effectiveness of its Cortoss bone augmentation material.

Results from the two multi-centre studies were published in the medical journal Spine this month, showing that Cortoss is able to provide pain relief and quality of life improvements to patients with osteoporotic vertebral compression fractures (VCFs).

These findings were reflected among patients receiving the material via both the vertebroplasty and kyphoplasty techniques of vertebral augmentation, with vertebroplasty requiring 50 per cent less material volume.

Dr Hyun Bae of The Spine Institute at Saint John's Health Center in Santa Monica, the lead author of the report, said: "These positive results formed the motivation and justification for us to continue to evaluate Cortoss in these patients."

This comes after Orthovita highlighted data presented by the Lancet last month, which underlined the advantages in pain relief terms of using vertebroplasty in the treatment of acute VCFs among elderly patients.ADNFCR-8000103-ID-800076735-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.